Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Pharmaceutical Retailers

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, comprising medicines, vitamins, medical devices, and test kits; and offers consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. The company also provides wholesale cash and carry; diagnostic, pathological, and laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. It operates stores in Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, and Puducherry, as well as online platform. The company was incorporated in 2006 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for MEDPLUS
Revenue projections for MEDPLUS

Investors may be wary of MedPlus Health Services Limited as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.

Financial Ratios:

currentRatio 3.001000
forwardPE 34.522392
debtToEquity 72.133000
earningsGrowth 0.241000
revenueGrowth 0.235000
grossMargins 0.262290
operatingMargins 0.050000
trailingEps 18.270000
forwardEps 25.544290

MEDPLUS's current ratio is 3.001, signaling that the company has sufficient cash reserves and current assets to cover its short-term debt obligations. This suggests financial stability, as MEDPLUS should not face any issues meeting its short-term liabilities with available resources.
MEDPLUS's positive earnings and revenue growth suggest that the company is poised for business expansion. This financial strength indicates that MEDPLUS is expected to continue growing, with rising profits and sales contributing to its long-term success.
MedPlus Health Services Limited's forward EPS exceeding its trailing EPS implies that the company is projected to be more profitable this year. This suggests an improvement in financial performance, with analysts expecting MedPlus Health Services Limited to generate stronger earnings compared to the previous financial year.

Price projections:

Price projections for MEDPLUS
Price projections for MEDPLUS

MEDPLUS's price projections have gradually increased over time, indicating that analysts are becoming more optimistic about the company's prospects. This suggests confidence in MEDPLUS's ability to achieve future growth.

Recommendation changes over time:

Recommendations trend for MEDPLUS
Recommendations trend for MEDPLUS


MedPlus Health Services Limited has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view MedPlus Health Services Limited as a stable option to park their money and potentially benefit from the company's continued growth and profitability.